Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01) - Concepedia

Concepedia

Publication | Open Access

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

DOI Full Paper Access

72

Citations

20

References

2016

Year

Patrick Ingiliz, Stefan Christensen, Torben Kimhofer, D. Hueppe, Thomas A. Lutz, Knud Schewe, Heiner Busch, G Schmutz, Malte H. Wehmeyer, Christoph Boesecke,

Clinical Infectious Diseases

Abstract

SL8 seems highly effective and safe in well-selected HCV-monoinfected and HIV-HCV-coinfected patients in a real-world setting.

References

	Year	Citations

Page 1